Successful Nilotinib therapy in an imatinib-resistant chronic myeloid leukemia patient displaying an intron-derived insertion/truncation mutation in the BCR-ABL kinase domain.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples